Palbociclib, Trastuzumab, Lapatinib and Fulvestrant Treatment in Patients With Brain Metastasis From ER Positive, HER-2 Positive Breast Cancer: A Multi-center, Prospective Study in China

Conditions:   Breast Cancer;   Brain Metastases Intervention:   Drug: Palbociclib, Trastuzumab, Lapatinib and Fulvestrant Sponsor:   wang shusen Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials